HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 44, 42171-42177, November 1, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/44/42171    most recent M207209200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kirsch, T. Articles by Pacifici, M. Search for Related Content PubMed PubMed Citation Articles by Kirsch, T. Articles by Pacifici, M. Social Bookmarking                      What's this?

Syndecan-3 Is a Selective Regulator of Chondrocyte Proliferation^*

Thorsten Kirsch^§, Eiki Koyama^¶, Mufei Liu^¶, Ellis E. Golub, and Maurizio Pacifici^¶

From the  Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland 21201 and the Departments of ^¶ Anatomy and Cell Biology and  Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Chondrocyte proliferation is important for skeletal development and growth, but the mechanisms regulating it are not completely clear. Previously, we showed that syndecan-3, a cell surface heparan sulfate proteoglycan, is expressed by proliferating chondrocytes in vivo and that proliferation of cultured chondrocytes in vitro is sensitive to heparitinase treatment. To further establish the link between syndecan-3 and chondrocyte proliferation, additional studies were carried out in vivo and in vitro. We found that the topographical location of proliferating chondrocytes in developing chick long bones changes with increasing embryonic age and that syndecan-3 gene expression changes in a comparable manner. For in vitro analysis, mitotically quiescent chondrocytes were exposed to increasing amounts of fibroblast growth factor-2 (FGF-2). Proliferation was stimulated by as much as 8-10-fold within 24 h; strikingly, this stimulation was significantly prevented when the cells were treated with both fibroblast growth factor-2 (FGF-2) and antibodies against syndecan-3 core protein. This neutralizing effect was dose-dependent and elicited a maximum of 50-60% inhibition. To establish specificity of neutralizing effect, cultured chondrocytes were exposed to FGF-2, insulin-like growth factor-1, or parathyroid hormone, all known mitogens for chondrocytes. The syndecan-3 antibodies interfered only with FGF-2 mitogenic action, but not that of insulin-like growth factor-1 or parathyroid hormone. Protein cross-linking experiments indicated that syndecan-3 is present in monomeric, dimeric, and oligomeric forms on the chondrocyte surface. In addition, molecular modeling indicated that contiguous syndecan-3 molecules might form stable complexes by parallel pairing of -sheet segments within the ectodomain of the core protein. In conclusion, the results suggest that syndecan-3 is a direct and selective regulator of the mitotic behavior of chondrocytes and its role may involve formation of dimeric/oligomeric structures on their cell surface.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A M Patterson, A Cartwright, G David, O Fitzgerald, B Bresnihan, B A Ashton, and J Middleton Differential expression of syndecans and glypicans in chronically inflamed synovium Ann Rheum Dis, May 1, 2008; 67(5): 592 - 601. [Abstract] [Full Text] [PDF]

				D. M. Beauvais, B. J. Burbach, and A. C. Rapraeger The syndecan-1 ectodomain regulates {alpha}v{beta}3 integrin activity in human mammary carcinoma cells J. Cell Biol., October 11, 2004; 167(1): 171 - 181. [Abstract] [Full Text] [PDF]

				K. J. McQuade and A. C. Rapraeger Syndecan-1 Transmembrane and Extracellular Domains Have Unique and Distinct Roles in Cell Spreading J. Biol. Chem., November 21, 2003; 278(47): 46607 - 46615. [Abstract] [Full Text] [PDF]